Related Experiment Video
Updated: Jul 22, 2026

Comprehensive & Cost Effective Laboratory Monitoring of HIV/AIDS: an African Role Model
Published on: October 31, 2010
Non-Tuberculous Mycobacterial Infection in AIDS Patients: A Detailed Description of 4 Cases, Including
Mario Oñat1, Alberto Fica2, Ignacio Delama2
1Universidad Austral de Chile, Valdivia, Chile.
Abstract:
Non tuberculous mycobacteria (NTM) are important opportunistic infection in patients with AIDS.
Aim:
To present 4 cases of disseminated infections by NTM in patients with AIDS.
Results:
These cases were associated with prolonged symptoms of fever, weight loss, diarrhea or cough, with hepatosplenomegaly, anemia and thrombocytopenia. None were receiving prophylaxis, had a low CD4 lymphocyte count (median 20/mm3), and three had discontinued their antiretroviral therapy (ART). The diagnosis was established by culture in bone marrow, sputum or bronchioalveolar lavage samples and in two cases also by PCR. Histological features included foamy histiocytes and positive acid fast bacilli in tissues. The species identified were Mycobacterium avium in 3 cases and M. genavense in the remaining case. Patients were treated with combinations of ethambutol, macrolides, quinolones, amikacin or rifampicin on a long-term basis (median 19 months) and even parenterally for severe diarrhea. Three patients survived and one died from disseminated Kaposi's sarcoma. Multiple complications were observed including severe malnutrition, renal failure, calcium and phosphorus metabolism disorders, healthcare-associated infections, co-infections, and neoplasms. All required readmissions and ART adjustments to compensate for interactions with rifampicin.
Conclusions:
NTM infections in patients with AIDS generate a prolonged morbidity, frequent readmissions, require an extended combination treatment that may present interactions with ART, and are associated with different complications, including calcium and phosphorus disorders. Its diagnosis is complex in the absence of special blood cultures, requiring a microbiological study in multiple samples and with different techniques, including the support of histopathology.
More Related Videos
10:10A 3D Human Lung Tissue Model for Functional Studies on Mycobacterium tuberculosis Infection
Published on: October 5, 2015
07:21Processing of Bronchoalveolar Lavage Fluid and Matched Blood for Alveolar Macrophage and CD4+ T-cell Immunophenotyping and HIV Reservoir Assessment
Published on: June 23, 2019
Related Concept Videos
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Tuberculosis